Lumos Pharma (LUMO) Announces Topline Data from Phase 2 OraG

Lumos Pharma (LUMO) Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary Endpoints

Lumos Pharma (LUMO) Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary Endpoints

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Washington , United States , Chile , Erick Hawkins , Fernando Cassorla , Aaron Rosenfeld , Lesliea Soyka , Andrew Dauber , Lumos Pharma , Endocrinology At Children National Medical Center , Umass Memorial Medical Center , Nasdaq , Child Research , Umass Chan Medical School , Lumos Pharma Inc , Institute Of Maternal , University Of Chile , Scientific Advisory Board , Least Squares Mean , Standard Error , Month Data , Pfizer Phase , Serious Adverse Events , Oragrowth Trial , National Medical Center , Pediatric Endocrinology , Memorial Medical Center , Associate Professor , Chan Medical School , Pediatric Growth Hormone Deficiency ,